Hexter Joshua

COO & CBO

Hexter Joshua has filed 7 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2026. 7 of those filings fall inside the rolling window. Most recent filing: Nov 14, 2026.

On the most recent filing, Hexter Joshua is listed as COO & CBO at ORAMED PHARMACEUTICALS INC. Inside the rolling window, Hexter Joshua reported no open-market purchases and 2 open-market sales totaling $747K in ORMP. The largest disclosed transaction in the window is a sale of 137,000 ORMP shares on Jul 1, 2026, worth $611K.

Companies traded

Other insiders at ORMP

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$747K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ORMPSale$135KOct 2SEC ↗
ORMPSale$611KJul 2SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Hexter Joshua made?

Hexter Joshua has filed 7 SEC Form 4 filings (11 transaction rows) across 1 company since 2026.

Which companies does Hexter Joshua trade?

Hexter Joshua has filed SEC Form 4 disclosures for 1 company, including ORMP.

When was Hexter Joshua's most recent SEC Form 4 filing?

Hexter Joshua's most recent SEC Form 4 filing on Tracefour is dated Nov 14, 2026.

What is Hexter Joshua's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Hexter Joshua is listed as COO & CBO.

What is Hexter Joshua's total buy and sell value in the current window?

Inside the rolling retention window, Hexter Joshua bought $0 and sold $747K based on SEC Form 4 filings.

What was Hexter Joshua's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 137,000 ORMP shares on 2026-07-01, worth $611K, per SEC Form 4 filings.